Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)

Hyundai Bioscience Revenue

Hyundai Bioscience had revenue of 332.91M KRW in the quarter ending June 30, 2025, a decrease of -96.37%. This brings the company's revenue in the last twelve months to 1.87B, down -89.23% year-over-year. In the year 2024, Hyundai Bioscience had annual revenue of 15.05B with 58.73% growth.

• Revenue (ttm): 1.87B
• Revenue Growth: -89.23%
• P/S Ratio: 266.60
• Revenue / Employee: 27.04M
• Employees: 69
• Market Cap: 497.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	15.05B	5.57B	58.73%
Dec 31, 2023	9.48B	1.63B	20.76%
Dec 31, 2022	7.85B	-1.39B	-15.04%
Dec 31, 2021	9.24B	-3.27B	-26.14%
Dec 31, 2020	12.51B	-17.57B	-58.41%